New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177)

Published:2022-09-14 Issue:19 Volume:65 Page:13001-13012
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zha Zhihao¹,Choi Seok Rye¹,Li Linlin²,Zhao Ruiyue²,Ploessl Karl¹^ORCID,Yao Xinyue²,Alexoff David¹,Zhu Lin²,Kung Hank F.¹³^ORCID

Affiliation:

1. Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States

2. College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China

3. Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

Funder

Five Eleven Pharma Inc.,

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00852

Reference62 articles.

1. Cancer Statistics, 2021

2. Prostate-specific membrane antigen theranostics in advanced prostate cancer: an evolving option

3. PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy

4. Simple new method for labelling of PSMA-11 with 68Ga in NaHCO3

5. Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders;Nuclear Medicine and Biology;2024-11

2. ⁶⁸Ga/¹⁷⁷Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer;Journal of Medicinal Chemistry;2024-07-29

3. Development of a Supermolecular Radionuclide-Drug Conjugate System for Integrated Radiotheranostics for Non-small Cell Lung Cancer;Journal of Medicinal Chemistry;2024-06-19

4. Novel [⁶⁸Ga/¹⁷⁷Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy;Molecular Pharmaceutics;2024-06-10

5. Covalent targeted radioligands potentiate radionuclide therapy;Nature;2024-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3